Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
24.12.25
/
50%
€2.44
Target price
24.12.26
€8.47
Performance (%)
41.86%
Price
13.03.26
€3.46
Summary
This prediction is currently active. With a performance of 41.86% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 24.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -21.720% | -21.720% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics (NASDAQ:IOVA) had its price target raised by analysts at Barclays PLC from $9.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.57
25.02.26
25.02.26
€9.33
25.02.27
25.02.27
-3.11%
13.03.26
13.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
111.99%
13.03.26
13.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
15.49%
13.03.26
13.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25